Jefferies Group’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,961
Closed -$55 1472
2020
Q2
$55 Buy
+1,961
New +$34.1K ﹤0.01% 1153
2020
Q1
Sell
-11,329
Closed -$123K 2432
2019
Q4
$123K Sell
11,329
-20,232
-64% -$200K ﹤0.01% 2353
2019
Q3
$403K Buy
31,561
+30,261
+2,328% +$436K ﹤0.01% 1997
2019
Q2
$22K Sell
1,300
-7,800
-86% -$134K ﹤0.01% 2419
2019
Q1
$164K Buy
+9,100
New +$157K ﹤0.01% 2002

Other funds holding MGNX

Jefferies Group's MGNX Position: Q3 2020 in Review

Jefferies Group sold out of MacroGenics (MGNX) in Q3 2020, closing a stake of 1,961 shares — an estimated $55 sold.

Jefferies Group first reported a position in MGNX in Q1 2019 and held it in 5 quarters. The position peaked at $403K in Q3 2019. 139 funds tracked by Wall St. Rank hold MGNX as of Q3 2020.

  • Jefferies Group reported no remaining MacroGenics position as of Q3 2020 after selling out during the quarter.
  • Jefferies Group sold 1,961 MacroGenics shares in Q3 2020, an estimated $55.
  • Jefferies Group first reported a position in MacroGenics in Q1 2019 and held it in 5 quarters.
  • Jefferies Group's MacroGenics position peaked at $403K in Q3 2019.
  • 139 funds tracked by Wall St. Rank held MacroGenics as of Q3 2020.

Based on Jefferies Group's 13F filing for Q3 2020, filed 13 Nov 2020.